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Abstract
The human gut microbiota comprise a complex and dynamic ecosystem that profoundly affects host development and
physiology. Standard approaches for analyzing time-series data of the microbiota involve computation of measures of
ecological community diversity at each time-point, or measures of dissimilarity between pairs of time-points. Although
these approaches, which treat data as static snapshots of microbial communities, can identify shifts in overall community
structure, they fail to capture the dynamic properties of individual members of the microbiota and their contributions to the
underlying time-varying behavior of host ecosystems. To address the limitations of current methods, we present a
computational framework that uses continuous-time dynamical models coupled with Bayesian dimensionality adaptation
methods to identify time-dependent signatures of individual microbial taxa within a host as well as across multiple hosts.
We apply our framework to a publicly available dataset of 16S rRNA gene sequences from stool samples collected over ten
months from multiple human subjects, each of whom received repeated courses of oral antibiotics. Using new diversity
measures enabled by our framework, we discover groups of both phylogenetically close and distant bacterial taxa that
exhibit consensus responses to antibiotic exposure across multiple human subjects. These consensus responses reveal a
timeline for equilibration of sub-communities of micro-organisms with distinct physiologies, yielding insights into the
successive changes that occur in microbial populations in the human gut after antibiotic treatments. Additionally, our
framework leverages microbial signatures shared among human subjects to automatically design optimal experiments to
interrogate dynamic properties of the microbiota in new studies. Overall, our approach provides a powerful, general-
purpose framework for understanding the dynamic behaviors of complex microbial ecosystems, which we believe will
prove instrumental for future studies in this field.
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Introduction
The human gut harbors a dense and complex microbial
ecosystem. Our ability to extensively characterize the microbiota
has greatly increased in the last several years, due to lower costs
and technical improvements in both DNA sequencing [1] and
bioinformatics tools [2,3]. High-throughput sequencing-based
studies of the microbiota generally analyze regions of the
conserved 16S ribosomal subunit gene [4], or use shotgun
sequencing to sample the entire repertoire of genes present in a
complex, mixed population of microbes [5–8]. These studies, of
either human subjects or animal models, have uncovered
intriguing associations between the composition of the gut
microbiota and various diseases, including obesity [8], inflamma-
tory bowel disease [7,9], and multiple sclerosis [10].
Longitudinal studies of the microbiota are particularly impor-
tant for further advancing the field [3,5,6,11–13]. The majority of
such longitudinal studies have been observational, monitoring the
composition of the flora in healthy individuals over time at various
body sites [3,5,6,11]. Such observational studies are valuable for
understanding natural variations in commensal communities, as
well as capturing rarer events such as onset and resolution of acute
disease in the host. Additionally, interventional studies have been
performed, in which subjects were intentionally exposed to agents
that perturb the microflora, with subsequent evaluation of changes
in host ecosystems over time [12,13]. Such interventional studies
hold promise for discovering the mechanisms by which microbes
interact with one another and the host, and to define how sub-
communities of micro-organisms may cause or protect against
disease.
To date, longitudinal studies of the microbiota have largely
employed static analysis techniques that do not adequately capture
the dynamic nature of the data. The most common types of
analyses employed involve either computation of diversity
measures, such as the Shannon-Weaver diversity index [14], at
each data point, or measures such as Unifrac [15] or Bray-Curtis
dissimilarity [16], which characterize pair-wise relationships
between data points. These techniques have proven useful for
uncovering certain trends in longitudinal data [3,6,8,11,12].
However, these techniques treat longitudinal data as a collection
of static snapshots, and ignore inherent ordering and other
temporal dependencies.
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called Microbial Counts Trajectories Infinite Mixture Model
Engine (MC-TIMME), which provides a unified framework for
analyzing the dynamic behavior of the microbiota captured via
high-throughput sequencing data. Our framework models time-
varying counts of microbial taxausing exponential relaxation
processes. Each relaxation process is characterized by a transient
effect level (the amplitude of the process immediately after a
perturbation), an equilibrium level (the amplitude of the process
approached as time tends to infinity), and a relaxation time constant
(the time required for the amplitude of the process to reach 33% of
the transient effect level plus 67% of the equilibrium level, as
measured on a logarithmic scale).Observed abundances of taxa are
assumed to arise from an infinite mixture of prototype signatures.
Each prototype signature is composed of a set of relaxation
processes that model a response to multiple perturbations. Each
reference operational taxonomic unit (refOTU) in the ecosystem(s)
analyzed is probabilistically assigned to a prototype signature.
Adaptive Bayesian techniques are used to model the dimension-
ality of prototype signatures and the extent of sharing of prototype
signatures among refOTUs within and across ecosystem(s).The
time-series of observed counts for a particular refOTU in an
ecosystem is modeled through a generative process, in which the
prototype signature to which the refOTU has been assigned is
customized to an individual signature by addition of refOTU and
time-point specific offset terms. Data is then generated from a
discrete-valued noise model parameterized by the individual
signature.
MC-TIMME enables several new types of analysis. The first
type, termed Signature Diversity (SD) analysis, measures the
variety of time-dependent microbial responses to perturbations to
the host ecosystem(s). SD utilizes time-varying information, and is
thus distinct from traditional static measures of ecological diversity
[17], which characterize the complexity of a microbial community
in terms of its constituent members at a single point in time. The
second type, Relaxation Time Distribution (RTD) analysis,
estimates the distribution of times required for members of the
host ecosystem(s) to equilibrate after a perturbation event. This
analysis summarizes the kinetics of responses, which is useful for
understanding the phasing of changes within microbial ecosys-
tems. The third type, Consensus Signature Group (CSG) analysis,
identifies sub-communities of microbes within the larger ecosys-
tem(s) that exhibit coordinated responses to a set of perturbations.
This latter analysis provides information about which microbes
may form functional sub-populations that affect the host or other
microbial populations over time. Finally, MC-TIMME enables
automated design of longitudinal studies of the microbiota. Our
method couples information theoretic and Bayesian approaches to
estimate from prior data the optimal sets of time-points to be
sampled in future experiments. In this manner, data from a pilot
study can be leveraged to develop optimized experimental designs
for larger studies.
MC-TIMME has some similarities to previously published
methods for analyzing other types of high-throughput data.
Several studies have employed continuous-time models [18–21]
or infinite mixture models [22,23]to analyze time-series micro-
array data. Methods for optimal experimental design for time-
series microarray data have also been described [24]. However,
methods designed for analyzing gene expression data do not model
dynamics inherent in complex microbial ecosystems, such as
equilibrium reverting behavior. Further, these methods generally
assume observed data are continuously valued and normally
distributed, which is reasonable for microarray data, but not
sequencing data, which consist of counts. Extensive statistical
literature has documented that, for data consisting of discrete
counts, direct modeling of the data yields superior results as
compared to transforming data to continuous values (see e.g., [25–
27]). This issue has been recognized for RNA Seq data, and
several methods have been developed that use discrete-valued
noise models [28–30]. Recently, Holmes et al. [31]presented a
method for modeling microbial metagenomics counts data that
also uses discrete-valued distributions. However, in contrast to
MC-TIMME, these methods for analyzing RNA Seqor metage-
nomics count data use only static models.
To gain new understanding of dynamic changes in the human
gut microbiota caused by antibiotic exposure, we applied MC-
TIMME to data from a longitudinal study by Dethlefsen et al. [12].
Despite the profound effects antibacterial agents presumably have
on commensal species in vivo, remarkably little is known about the
rates at which these complex ecosystems recover or remain altered
after cessation of a course of antibiotics. Further, it remains poorly
understood how antibiotic-induced changes in the microbiota
affect underlying host physiology, including enhanced susceptibil-
ities to other pathogens [32], disease states such as allergic and
auto-immune responses [33,34], and acute or chronic effects on
host diet and metabolism [35].To date, the Dethlefsen et al. study
provides the longest time-series systematically monitoring the
effects of antibiotics on human gut commensals. In this study,
human subjects were given two spaced five day courses of oral
ciprofloxacin, a broad-spectrum antibiotic that targets the DNA
gyrase and topoisomerases of many microbial species [36–40].
Subjects’ gut microbiota was monitored at 50+ time-points over
nearly a year, by sequencing 16S rRNA gene signatures present in
stool samples.
The remainder of the manuscript is organized as follows. First,
we provide additional background on the Dethlefsen et al. dataset
that we re-analyzed. Second, we describe the MC-TIMME
framework, including our model of dynamics, inference algorithm,
and automated experimental design method. Third, we apply
MC-TIMME to the Dethlefsen et al. data to demonstrate the utility
of Signature Diversity (SD), Relaxation Time Distribution (RTD),
Author Summary
Microbes colonize the human body soon after birth and
propagate to form rich ecosystems. These ecosystems play
essential roles in health and disease. Recent advances in
DNA sequencing technologies make possible comprehen-
sive studies of the time-dependent behavior of microbes
throughout the body. Sophisticated computer-based
methods are essential for the analysis and interpretation
of these complex datasets. We present a computational
method that models how human microbial ecosystems
respond over time to perturbations, such as when subjects
in a study are treated with a drug. When applied to a large
publicly available dataset, our method yields new insights
into the diversity of dynamic responses to antibiotics
among microbes in the human body. We find that within
an individual, sub-populations of microbes that share
certain physiological roles also share coordinated respons-
es. Moreover, we find that these responses are similar
across different people. We use this information to
improve the experimental design of the previously
conducted study, and to develop strategies for optimal
design of future studies. Our work provides an integrated
computer-based method for automatically discovering
patterns of change over time in the microbiota, and for
designing future experiments to identify changes that
impact human health and disease.
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tal design methods. Our results provide new quantitative insights
into how antibiotic exposures affect the human gut microbiota,
and how these dynamic alterations may influence the host.
Methods
Dataset Summary
Dethlefsen et al. [12] examined the microbiota from stool
samples of three human subjects over a 10 month period, using
Roche 454 high-throughput sequencing of PCR amplicons
spanning the V1, V2 and V3 regions of 16S rRNA genes,
producing a total of approximately 5 million reads. During the
study, each subject received two separate 5 day courses of oral
ciprofloxacin. Stool samples were collected daily during, one week
prior, and one week after the antibiotics courses, but otherwise
were collected less regularly throughout the study. Dethlefsen et al.
combined the sequencing reads from all subjects to produce 2,582
reference operational taxonomic units (refOTUs). However, they
found that only a few hundred refOTUs were present at
consistently detectable levels in at least one sample per subject.
In order to focus our analysis on refOTUs above the threshold of
detection of the sequencing assay, we required that refOTUs have
$5 counts for $10 time-points. This resulted in a total of 218
refOTUs for subject D, 261 for subject E, and 277 for subject F.
Dethlefsen et al. taxonomically labeled refOTUs using the Silva
100 Small Subunit Reference database [41], and UClust [42] with
a minimum best hit similarity of 95%. Data files containing counts
and taxonomic labels for refOTUs were downloaded from the
website linked to the original publication; DNA sequences for each
refOTU were not available.
MC-TIMME
Overview. MC-TIMME uses a Bayesian nonparametric
hierarchical generative probability model as depicted in Figure 1.
The ecosystem(s) analyzed are assumed to be decomposable into
probabilistic mixtures of functions, continuous in both time and
value,termedprototypesignatures(Figure 1A).Thedata generation
process probabilistically assigns each refOTU to a prototype
signature, which induces a clustering of refOTUs into groups that
share similar dynamics. The continuous-time prototype signature is
then sampled at observed time-points (Figure 1B). The prototype
signature is converted to an individual signature(Figure 1C) through
a refOTU specific scaling term, and an experiment-wide normal-
ization term that accounts for the total numbers of sequencing reads
across experiments. Finally, the observed data for each refOTU, a
time-series of counts, is generated from the individual signature
through a discrete-valued noise model (Figure 1D).
MC-TIMME adaptively learns three levels of Signature
Diversity (SD) as depicted in Figure 2. These three levels are:
(SD1) intra-signature (Figure 2A), or the dimensionality of each
prototype signature, (SD2) intra-ecosystem (Figures 2B,2C), or the
diversity of prototype signatures among the taxa within an
ecosystem, and (SD3) inter-ecosystem (Figures 2D,2E), or the
diversity of prototype signatures across multiple host ecosystems.
For SD1 adaptive learning, MC-TIMME employs latent variables
that control the number of parameters that specify each prototype
signature. For SD2, MC-TIMME incorporates Dirichlet Process
infinite mixture models, which effectively adjust the number of
prototype signatures used to model the system. ForSD3, MC-
TIMME maps experiments from different ecosystems to the same
time-scale for simultaneous analysis, facilitated by the continuous-
time model of dynamics.
The MC-TIMME model is fully Bayesian, and we thus seek to
infer the posterior probability distribution of the model variables
given the data. However, the posterior distribution is not
computable in closed form, making exact inference intractable.
Instead, we approximate the posterior distribution using Markov
Chain Monte Carlo (MCMC) methods, and then compute various
summary statistics. Below, we provide further information on the
MC-TIMME model and associated algorithms; see Protocol S1
for complete details.
Sample data, instructions, and GPLv3 licensed Matlab
TM
(MathWorks, Natick, MA) source code for MC-TIMME are
available at https://sourceforge.net/projects/mctimme/. The
implementation provided will process datasets with an arbitrary
number of experimental subjects or perturbations, as specified
through user supplied data files.
Dynamical model for antibiotic pulses. Prior longitudinal
studies have qualitatively described several key dynamic properties
of the gut microbiota [3,12]. First, abundances of individual
microbes within a stable ecosystem are constrained around
average levels, despite day-to-day temporal variability. Second,
when the ecosystem is perturbed, individual members exhibit
varied responses. These responses are characterized by transient
components that eventually decay toward an equilibrium state. Of
note, this equilibrium state may differ from the pre-perturbation
state. Third, the responses of micro-organisms within the
ecosystem are dependent on one another. These dependencies
may be multifactorial, including factors such as competition for
nutrients and other essential resources, as well as common
reactions to phases of the host immune response.
To model these phenomena for the Dethlefsen et al. data, we
assume that the dynamics for each refOTU are characterized by
piece-wise defined functions over five intervals delimited by the
antibiotic treatments in the experiment (Figure S1). These five
intervals are: (a) pre-antibiotic, (b) antibiotic treatment one, (c)
post-antibiotic treatment one, (d) antibiotic treatment two, and (e)
post-antibiotic treatment two.
Observed sequencing counts ysot for subject s, refOTUo, and at
time t are assumed to be samples from the negative binomial
distribution (NBD), a two parameter distribution [25]. The density
function of the NBD can be parameterized in terms of its mean m
and inverse shape parameter e. Thus, for ysot the NBD density
function is given by:
NBD(ysot;msot,e)~
C(ysotz1=e)
C(1=e)ysot!
: msot
ysote{1=e
(msotz1=e)
ysotz1=e
Let each prototype signature k be associated with a deterministic
function f(t,hk). We then specify the mean of the NBD msot at time t
for refOTUo in subject s assigned to prototype signature k as:
msot~ef(t,hk)zcsozwst
The variable cso is a subject and refOTU specific offset that scales
the baseline number of counts for refOTUo in subject s. The
variable wst is a subject and time-point specific offset that accounts
for differences in the total number of sequencing reads among
experiments for subject s.
For intervals (a), (b) and (d), we assume f(t,hk) is constant valued,
i.e., fa(N)=mka,f b(N)=Xkb, and fd(N)=Xkd. We assume that dynamics
in interval (c), the period after the first antibiotic treatment and
before the second, are specified by an exponential relaxation
process:
Inferring Dynamic Signatures of Microbes
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This process has initial value Xkb, modeling the transient effect of
the antibiotic treatment, and approaches equilibrium level mkc with
relaxation time lkc.
For interval (e), the period after the second antibiotic treatment,
we also assume an exponential relaxation process:
fe(t,Xkd,mke,lke)~Xkde{t=lkezmke(1{e{t=lke)
For the NBD inverse shape parameter, we assume it is equal to the
same value, e1, on intervals (a), (c) and (e), and equal to a different
value, e2, on the antibiotic treatment intervals (b) and (d).
To capture behavior of the microbiota that spans multiple
temporal intervals, we model dependencies between interval
parameters using random walks. For instance, the equilibrium
level on interval (c), mkc, for the prototype signature k is given by:
mkc~mkazdka?c
Here, mka is the pre-treatment equilibrium level, and dkaRc is a
random, normally distributed increment. We model relationships
between the other interval parameters similarly, as described fully
in Protocol S1.
To adapt the complexity of the dynamical models for prototype
signatures, we introduce dimensionality changing variables, ckm
and ckl. These variables are discrete-valued, and act as ‘‘switches’’
to control the number of equilibrium levels or relaxation time
parameters utilized by each prototype signature.
Model inference and posterior distribution
summarization. We approximate the posterior distribution of the
MC-TIMME model using Markov Chain Monte Carlo (MCMC)
methods. The DirichletProcess aspects of the model are handled with
Gibbs sampling steps [43]. Updating prototype signature variables is
more involved, because of temporally induced dependencies among
variables, non-conjugacy of prior distributions, and the dimensionality
changing variables. For these updates, we use combined Reversible
Jump/Metropolis-Hastings steps. See Protocol S1 for complete details.
We ran our MCMC algorithm with a burn-in of 10,000 iterations, and
then collected every 10th sample for an additional 5,000 iterations.
Convergence was evaluated using standard techniques as described in
[44]. Eight independent MCMC runs were pooled for our final
analysis. This produced a set of J=4,000 posterior samples, which
were then used to compute summary measures for Signature Diversity
(SD), Relaxation Time Distribution (RTD), and Consensus Signature
Group (CSG) analysis.
Figure 1. Schematic of the Microbial Counts Trajectories Infinite Mixture Model Engine (MC-TIMME) generative probabilistic
model. Observed data of time-series of sequencing counts for reference operational taxonomic units (refOTUs) are assumed to arise from a multi-
level generative probabilistic mixture model.(A)Infinite mixture over latent prototype signatures (green, red and blue solid lines),which specify
models of dynamics continuous in both time and amplitude. The horizontal axis for each prototype signature represents time, and the vertical axis
represents amplitude. Prototype signatures may adapt their dimensionality, which is shown increasing from left to right. The variables pi and
associated shaded bars represent prior probabilities for choosing among prototype signatures. (B)For each refOTU, a prototype signature is
probabilistically chosen and sampled at discrete observed time-points. (C)Experiment and refOTU specific variables are added to the selected
prototype signature to create an individual signature. (D) Observed data, consisting of sequencing counts, is generated through a discrete-valued
noise model parameterized by individual signatures generated in step C.
doi:10.1371/journal.pcbi.1002624.g001
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score, SD1m, as the expected fraction of refOTUs with greater
than one equilibrium level. We similarly define the SD1 relaxation
time score, SD1l, as the expected fraction of refOTUs with greater
than one relaxation time constant. The SD1 scores are given by:
SD1m(s)~
X
j
X
k
n
(j)
skI(c
(j)
kmw1)=OsJ
SD1l(s)~
X
j
X
k
n
(j)
skI(c
(j)
klw1)=OsJ
Here, I(N) denotes the indicator function, nsk
(j) the number of
refOTUs from subject s assigned to prototype signature k in
MCMC sample j, and Os the number of refOTUs for subject s.
We define the Signature Diversity type 2 (SD2) score as the
expected equivalent number of prototype signatures per 100
refOTUs. Because assignment of refOTUs to prototype signatures
may be non-uniform, we use a measure that standardizes for this
effect. The SD2 score is given by:
SD2(s)~100
X
j
eHs(n(j)
s )=OsJ
Here, Hs(ns
(j)) represents the entropy with respect to the
distribution over assignments to prototype signatures for sample
j, restricted to subject s. The exponentiated entropy yields the
equivalent number of prototype signatures: the hypothetical
number of prototype signatures, assuming a uniform assignment
of refOTUs, which will yield an entropy equal to Hs(ns
(j)).
We define the Signature Diversity type 3 (SD3) score as a ratio
of SD2 scores: SD2
D, which is an SD2 score computed on a
hypothetical combined ecosystem, and SD2
I, which is the
weighted average of independent SD2 scores computed on each
ecosystem separately. These scores are given by:
SD2D~100
X
j
eH(n(j))=J
X
s Os
SD2I~100
X
s
SD2(s)Os=
X
s Os
Here, H(n
(j)) represents the entropy with respect to the distribution
over assignments to prototype signatures for sample j for all
subjects’ ecosystems combined.
To characterize Relaxation TimeDistributions, we estimated
probability density functions for relaxation time constants of all
refOTUs, using the ksdensitykernel density estimation function
in MatlabR2011b with the default options.
To characterize Consensus Signature Groups (CSGs), we used
an agglomerative clustering method as described in [23]. For each
pair of refOTUso and o9 in subjects s and s9 (possibly the same
subject) we computed:
pso,s’o’~
X
j
I(z(j)
so~z
(j)
s’o’)=J
Here, z
(j) is a random variable that specifies the assignment of a
refOTU to a prototype signature for MCMC iteration j. The
agglomerative clustering method successively merges CSGs based
on average linkage using pso,s9o9 as the similarity measure. Merging
is stopped when the number of clusters reaches the expected
number of prototype signatures, as calculated from all the MCMC
samples. Consensus signatures and relaxation time constants for a
CSG are then computed from the MCMC samples for all
refOTUs belonging to that CSG.
To test for enrichment of Consensus Signature Groups for
particular taxonomic labels, we used the following procedure. For
each CSG, we computed p-values for the observed configuration
of taxonomic labels of refOTUs at the order, family and genus
levels, under the null hypothesis that configurations followed the
hypergeometric distribution. We computed the false discovery rate
(FDR) using the method of [45], and considered cases with
FDR,0.05 significant.
Experimental Design
Our approach is based on a Bayesian information theoretic
formulation of the experimental design problem (see e.g., [46–48]).
To define notation, suppose we are given a joint probability
distribution p(H,A(T)) over model parameters H and possible data
A(T) collected at a set of time-points T. Suppose we then perform
experiments, which allow us to collect a dataset denoted a. This
results in a gain in Shannon information that is given by:
=fp(H,A(T)~a)g~Hfp(H)g{Hfp(HDA(T)~a)g
Here, H{N} denotes the differential entropy. Thus, we see that the
gain in information is due to the difference in entropy between
prior and posterior distributions.
The objective of our automated experimental design algorithm
is then to choose the sampling times T that maximize the expected
information gain over all possible data that could be observed at
those time-points:
EA(T)½=fp(H,A(T))g ~
ð
p(H,A(T))log
½fp(H,A(T))=p(A(T))gp(H) dA(T)dH
This is a high dimensional integral that is in general intractable.
However, for a linear model with Gaussian noise, the integral can
be written as [46,49,50]:
ð
logfDIM(H;T)Dgp(H)dH
Here, IM denotes the Fisher information matrix, and |N| the
determinant of the matrix. The integral can be approximated with
a function g(N) of samples H
(j) from the priorp(H), yielding:
EA(T)½=fp(H,A(T))g &g(T,H
(1),...,H
(J))
~
X
j
logfjIM(H
(j);T)jg=J
In the case of a Generalized Linear Model, a linear approximation
can be calculated to yield a local Bayesian D-optimality measure
[50]. We use this measure, as each prototype signature in MC-
TIMME is a Generalized Linear Model if we condition on the
appropriate parameters (see Protocol S1).
We estimate samples from p(H), the prior probability distribu-
tion over model parameters for future experiments, using a model
learned from previously observed data. Specifically, we use 500
MCMC samples obtained from the posterior distribution of the
MC-TIMME model conditioned on a set of observed data. We
then use a greedy optimization algorithm with the Bayesian D-
optimality function g(N)defined above, to generate experimental
designs. See Protocol S1 for complete details.
Inferring Dynamic Signatures of Microbes
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Algorithm Performance
MC-TIMME analyzed the complete Dethlefsen et al. dataset,
consisting of 3 subjects with 50+ time-points each, in approx-
imately 12 hours on an Intel Xeon E5507 2.27 GHz core. Figure
S2 provides examples of individual signatures for refOTUs
inferred by MC-TIMME. The subsequent sections detail our
biological findings based on these analyses.
We also ran additional analyses to evaluate the sensitivity of our
results to key model assumptions or features of the data. First, we
tested the robustness of the model’s dimensionality adaptation
capability, which is a critical component of Signature Diversity
scores. These tests showed no significant differences in our results
when relevant model parameters were varied. Second, we tested
the robustness of our results to noise. Because an equivalent gold
standard experimental dataset does not exist, we generated
simulated data for use in testing. For these simulations, we used
all prototype signatures estimated by MC-TIMME from the full
Dethlefsen et al. dataset as our gold standard, and then generated
test datasets with varying amounts of added noise. When the
amount of noise equaled that in the original dataset (coefficient of
variation of <60% for counts), MC-TIMME recovered Signature
Diversity scores with ,<10% error, and relaxation time constant
estimates with <25% error for the first post-antibiotic exposure
interval, and <40% error for the second interval; measures of
consistency of assignment of refOTUs to prototype signatures
showed <20% reduction in quality. Third and finally, we tested
the sensitivity of our results to exclusion of each experimental
subject. These tests showed error rates comparable to those from
our simulations when noise levels were equal to those in the
original dataset. See Protocol S1 for complete details. Overall, our
model performance tests demonstrate that our results are robust to
changes in relevant parameter settings, noise, and exclusion of
experimental subjects.
Signature Diversity
To characterize the diversity of responses of the microbiota to
repeated antibiotic treatments, we calculated three types of
Signature Diversity (SD) scores. As shown in Figure 2, each SD
score (SD1 to SD3) measures the dynamic behavior of micro-
organisms in the host ecosystem(s) at a different level of resolution.
These scores take into account the responses over time for
refOTUs, and thus provide new information about dynamic
properties of the ecosystems studied, as compared to traditional
static measures of ecological diversity [17].
The intra-signature diversity (SD1) scores for all three subjects
in the Dethlefsen et al. study were .<50% (Figures 3A, 3B),
indicating that the majority of micro-organisms in these host
ecosystems exhibited changes in equilibrium levels or relaxation
times after one or both antibiotic treatments. As shown in
Figures 3A and 3B, the SD1 score has two components: (1) SD1m,
which measures the expected fraction of refOTUs with changes in
equilibrium levels between pre-treatment and at least one post-
antibiotic treatment interval, and (2) SD1l, which measures the
expected fraction of refOTUs with changes in relaxation time
constants between the two antibiotic treatment intervals. The
intra-ecosystem signature diversity (SD2) score was <8–20
expected equivalent signatures per 100 refOTUs (Figure 3C),
indicating that many micro-organisms within each host ecosystem
exhibited similar responses to the antibiotic treatments. Stated
another way, a typical refOTU in a subject’s gut ecosystems
shared a similar response with <5–12 other refOTUs.
These analyses indicated that subject E’s gut microbiota
exhibited fewer long-term shifts in abundance levels and
responded overall more uniformly to the antibiotic exposures.
That is, subject E had significantly lower intra-signature and intra-
ecosystem Signature Diversity scores, with an SD1mscore of 50%
and SD2 score of 10, as compared with the other two subjects with
SD1m scores .70% and SD2 scores <20. This differential
behavior of subject E’s microbiota was not discernible in the
original analysis performed by Dethlefsen et al., as they did not use
techniques that quantified diversity of temporal responses. Our
Signature Diversity analysis thus provides additional information
about the functional diversity of subject E’s microbiota, suggesting
that this subject may have harbored a more ciprofloxacin-resistant
flora prior to the experiments. Of note, subjects in the study had
not received antibiotics in the past year before the experiments,
but their antibiotic exposure history prior to this point was
unknown.
The inter-ecosystem signature diversity (SD3) score for the 3
subjects was 48%(p-value,10
26using a permutation test with null
hypothesis of independent ecosystems), indicating that there were
substantial similarities in the time-dependent responses of the
subjects’ microbiota to the antibiotic treatments. As shown in
Figure 3D, the SD3 score is a ratio of two SD2 scores: (1) SD2
D,
which is computed on a hypothetical combined ecosystem, in
which refOTUs from different subjects probabilistically share
prototype signatures, and (2) SD2
I, which is a weighted average of
independent SD2 scores computed separately on each subject.
The SD3 score of 48% indicates that approximately as many
prototype signatures were shared among the subjects as were
unique to each subject. Thus, although subjects’ microbiota did
exhibit varied responses to the antibiotic treatments, as reported in
the Dethlefsen et al. study, our findings indicate that there were
substantial commonalities among responses. These commonalities
could not have been found using the analysis techniques of the
original study, which relied on calculations at individual time-
points, in part because different sampling times for each subject
made point-wise comparisons impossible. In contrast, MC-
TIMME uses a continuous-time model of dynamics that leverages
information from multiple time-points to estimate key dynamical
properties, allowing comparisons across subjects on a common
time-scale.
Relaxation Time Distributions and Consensus Signature
Groups
We generated Relaxation Time Distribution (RTD)plots using
data from all three subjects, to investigate common trends in the
rates at which the microbiota attained equilibrium levels after
repeated antibiotic exposures (Figure 4). These plots depict
estimated smoothed probability distributions of relaxation time
constants, in units of days, for all refOTUs across all subjects. As
shown in Figure 4, the Relaxation Time Distribution for the first
post-antibiotic exposure interval is multi-modal. A large peak in
the distribution at <1–3 days indicates that many refOTUs
quickly reached equilibrium levels, while a subsequent broader
peak suggests waves of microbial succession events among
subpopulations that took longer to equilibrate. Interestingly, after
the second antibiotic exposure, the relaxation time distribution
became simpler and more concentrated, with more refOTUs
exhibiting relaxation times around <1–3 days. This finding
suggests that the first antibiotic treatment shifted gut ecosystems
toward more rapidly equilibrating states, possibly by selecting for
more antibiotic resistant organisms or for sub-communities that
more quickly and stably established themselves in relevant niches.
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microbial sub-communities to antibiotic exposures, we next
generated Consensus Signature Groups (CSGs), which represent
groups of refOTUs that consistently covary in terms of relative
abundances over time. Combining data from all subjects, MC-
TIMME identified 125 CSGs. Interestingly, many of the CSGs
contained refOTUs that are phylogenetically related or are
common to all subjects. To assess the phylogentic relationships
among refOTUs within each CSG, we calculated an enrichment
p-value for taxonomic labels at the order, family and genus levels,
based on a hypergeometric distribution null hypothesis. Approx-
imately 61% of refOTUs belonged to CSGs significantly enriched
for at least one taxonomic label at these levels, with most such
CSGs shared across subjects. These results provide evidence that
MC-TIMME detected biologically relevant sub-communities of
organisms based only on evaluation of time-varying behaviors of
Figure 2. Schematics of microbial ecosystems illustrating Signature Diversity scores at multiple levels of resolution. The panels depict
examples of simplified microbial ecosystems measured over time, to illustrate three levels of Signature Diversity (SD) scores computed by the
Microbial Counts Trajectories Infinite Mixture Model Engine (MC-TIMME) framework. (A) Intra-signature diversity (SD1), characterizes the
dimensionality of each prototype signature. The top panel depicts a prototype signature with a lower SD1 score than the prototype signature in the
bottom panel, which exhibits different equilibrium levels and relaxation time constants on each of the shaded intervals. (B–C) Intra-ecosystem
signature diversity (SD2), characterizes the extent of prototype signature sharing among taxa within a host ecosystem. Host ecosystem (B) has a lower
SD2 score than (C), because all taxa in (B) share the same prototype signature. (D–E) Inter-ecosystem signature diversity (SD3), characterizes the
extent of prototype signatures haring across ecosystems. Each panel depicts two ecosystems. The two ecosystems in (D) have a lower SD3 score than
those in (E), because more prototype signatures are shared between the ecosystems in D.
doi:10.1371/journal.pcbi.1002624.g002
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exhibited consistent behavior across all subjects: 88refOTUs were
present in all 3 subjects, and of these 88 refOTUs, <25% were
assigned to common CSGs. These sets of refOTUs, which
consistently covary across all subjects, could serve as candidate
biomarkers in future studies of antibiotic treatments or other
perturbations to the gut flora.
We created a time-line of the largest and best taxonomically
defined Consensus Signature Groups (Figure 5A–M), to gain
insight into the specific responses and successive equilibration of
gut commensal sub-populations after antibiotic exposures. For
purposes of visualization, we ordered the CSGs according to their
relaxation time constants after the first antibiotic pulse, as these
relaxation times exhibited the most variation. To facilitate
interpretation, we included only CSGs containing at least one
refOTU shared among all subjects, and significantly enriched
(false discovery rate,0.05, hypergeometric tests)for at least one
taxonomic label at the family or genus level. These criteria yielded
13 CSGs, containing <50% of all refOTUs. Of the 13 CSGs, 8
exhibited decreases in relative abundance during the first
antibiotic pulse (Figure 5A–H), and 5 respectively exhibited
increases (Figure 5I–M).
Among Consensus Signature Groups showing decreases in
relative abundance during the first antibiotic pulse, those
containing refOTUs in the genus Bacteroides (Figure 5A,C), or
refOTUs in the related family Porphyromonadaceae (Figure 5D),
were among the first groups to equilibrate after cessation of
antibiotics. These groups of refOTUs had relaxation times ,<2
weeks, and returned to the same or higher relative abundances as
compared to those prior to the first antibiotic pulse. The Bacteroides
[51]are obligate anaerobes. Members of this genus, in particular B.
fragilis, are known to have greater resistance to ciprofloxacin,
mediated in part by several bacterial factors, coupled with reduced
activity of the antibiotic under anaerobic conditions [40,52]. The
Bacteroides can also be opportunistic pathogens and are capable of
developing resistance to multiple classes of antibiotics after
repeated exposures [53,54]. These characteristics may explain
why the Bacteroides were among the first genera found by MC-
TIMME to recover post-antibiotic treatment. Interestingly,
another CSG significantly enriched for refOTUs of genus
Bacteroides (Figure 5M) exhibited an increase in relative abundance
during antibiotic treatment, with a very slow return to equilibrium
levels (relaxation time <42 days). This finding suggests that
subjects consistently harbored antibiotic resistant Bacteroides,
echoing concerns that members of this genus could serve as
reservoirs of resistance genes for more frankly pathogenic bacteria
[53,54].
MC-TIMME also identified another quickly equilibrating sub-
community that contained refOTUs belonging to acetate [55] and
butyrate [56] producing genera (Figure 5I). This sub-community
showed increases in relative abundance during antibiotic treat-
ments and was significantly enriched for refOTUs belonging to the
genera Blautia, Faecalibacterium,o rRoseburia. Many Blautia species
are acetogens, producing acetate from H2 and CO2 through the
acetyl-CoA pathway [55]. Acetate has known downstream effects
on the microbial production of butyrate [57]. Butyrate, a 4-carbon
short chain fatty acid, has important roles in maintaining colonic
health of the host, providing a luminal source of energy to the
epithelial barrier [57], while limiting the degree of autophagy in
host colonocytes and reducing the host’s susceptibility to agents
that might otherwise promote damage to the colonic mucosa [58].
Members of the genera Faecalibacterium and Roseburia are prominent
butyrate producers in the human gut [56]. Our CSG analysis
suggests that the identified Blautia, Faecalibacterium, and Roseburia
refOTUs may operate as a functional multi-species community in
the gut, one demonstrating relative resilience tociprofloxacin’s
effects. This finding highlights MC-TIMME’s ability to identify
and track over time and across multiple subjects, bacterial sub-
Figure 3. SignatureDiversity scores for gut microbiota of three human subjects treated twice with antibiotics. (A) Intra-signature
diversity scores for equilibrium levels (SD1m), which measure the expected fraction of reference operational taxonomic units (refOTUs) that change
equilibrium levels in response to one or more of the antibiotic treatments. (B) Intra-signature diversity scores for relaxation times (SD1l), which
measure the expected fraction of refOTUs that exhibit different relaxation time constants after the antibiotic treatments. (C) Intra-ecosystem
signature diversity scores (SD2), which measure the expected equivalent number of prototype signatures per 100 refOTUs. (D) The inter-ecosystem
signature diversity score (SD3), which measures the degree of sharing of prototype signatures across host ecosystems, is a ratio of the SD2
Dto the
SD2
I score. The SD2
Dscore is computed on a hypothetical combined ecosystem, in which refOTUs from different subjects probabilistically share
prototype signatures. The SD2
I score is a weighted average of SD2 scores computed on each subject separately.
doi:10.1371/journal.pcbi.1002624.g003
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TIMME discovered a second CSG containing Blautia refOTUs,
but not the butyrate producing genera (Figure 5B),and that
exhibited a different response pattern, with a decrease in relative
abundance during the first antibiotic pulse, and relatively rapid
return to pre-antibiotic relative abundances. Of note, certain
Blautia species, such as B. hydrogenotrophica, use a broader range of
substrates for acetogenesis than other species in the genus
[55].The presence of such Blautia species with greater metabolic
flexibility in the CSG depicted in Figure 5B could explain the lack
of butyrate producers in this consensus signature group.
Several Consensus Signature Groups contained refOTUs
belonging to the family Ruminococcaceae (Figure 5F,G,H). These
CSGs showed decreases in relative abundance during the first
antibiotic pulse and equilibrated slowly thereafter. In fact, one
group of these organisms (Figure 5H), become undetectable after
the first antibiotic pulse, and another group (Figure 5F) declined to
very low relative abundance levels after the second pulse. The
Ruminococcaceae are overall obligately anaerobic, fastidious
organisms that may require substrates produced as by-products
of metabolism by earlier colonizers in gut luminal food-webs [57–
59]. Thus, the delay in which these consensus groups of
Ruminococcaceae recovered may be due to high degrees of
dependence on activities of other organisms in the ecosystem.
MC-TIMME also discovered a number of Consensus Signature
Groups containing refOTUs from the family Lachnospiraceae
(Figure 5E,J,K,L). The majority of these CSGs showed increases
during the antibiotic pulses, with fairly long relaxation times to
pre-antibiotic relative abundance levels. The Lachnospiraceae are
a large family of difficult to cultivate organisms, some of which
have been found in close association with the mucous layer over
the distal colonic epithelium [60]. Although little is known about
the antibiotic susceptibilities of these organisms, it has been
hypothesized that they may have evolved special mechanisms to
survive the higher concentrations of endogenously produced host
anti-microbial peptides present in this niche [60]. Our CSG
analysis identified distinct groups of refOTUs from the Lachnos-
piraceae family that exhibited prolonged increases in relative
abundance after ciprofloxacin exposure. These findings provide
new information about this poorly understood bacterial family,
which could be used to guide future studies to evaluate potential
mechanisms of innate antibiotic resistance among Lachnospir-
aceae sub-communities.
Automated Experimental Design
Application of metagenomic techniques to diagnostic medicine
will require human clinical trials across many subjects to ascertain
time-dependent effects and responses of the microbiota relative to
a defined perturbation or clinical course of disease. The
complicated logistics and expense of such trials highlight the need
for computational techniques to optimize sampling across subjects.
We developed an algorithm for automated experimental design,
and applied it to the Dethlefsen et al. dataset to explore how the
experimental design of a longitudinal study of the microbiota
could be improved for future, larger trials. Our algorithm uses the
data from a set of previously performed experiments to estimate an
initial model of prototype signatures. This initial model is used to
find a set of time-points that maximize the information that can be
gained from future, hypothetical experiments. In general, our
algorithm prioritizes time-points for sampling in future experi-
ments around time-points in the original experiment that had the
highest degree of uncertainty in the model. The selected time-
points may differ from those in the original experiments, and thus
indicate when increased sampling could better estimate dynamics
of the ecosystems under study, or when reduced sampling still
yields sufficient information.
Figure 6 depicts the optimized experimental design produced by
our algorithm for each subject. To facilitate comparisons among
designs, we restricted our algorithm to choose the same numbers of
time points as were used in the original design. Our algorithm
generated an optimal design that consistently differed from the
original design, over certain temporal intervals. On the pre-antibiotic
interval, the optimized design required more uniform sampling,
reflecting the modeling assumption that host ecosystems were at
equilibrium prior to antibiotic exposure. For the period immediately
after the first antibiotic exposure, the optimized design required
additional frequent sampling beyond the one week of the original
design. This increased sampling requirement is consistent with the
relaxation time distribution on the first post-antibiotic treatment
interval shown in Figure 4, which indicates the presence of transient
effects beyond one week for many refOTUs. However, the optimal
design required fewer subsequent samples on the first post-antibiotic
treatment interval, suggesting that MC-TIMME can effectively
leverage earlier time-points obtained while the ecosystem is still
equilibrating to estimate later behavior near steady-state. During the
period immediately after the second antibiotic exposure, the optimal
design generally required less frequent sampling than did the original
design. This reduced sampling requirement reflected the shorter
relaxation time distribution on the second post-antibiotic interval as
shown in Figure 4. Finally, the optimal design required considerably
more sampling at the end of the time-series; the original experiments
clearly under-sampled after the second antibiotic exposure, as is
evident from high variability in model parameter estimates on this
interval (see Figure 5 and Figure S2).
To assess the predictive accuracy of our experimental design
algorithm, we evaluated its ability to find a set of experiments to
best estimate a model to predict held-out data (Figure S3). We
used root mean square error (RMSE) to measure predictive
accuracy. RMSE is the square root of the sum of squared
Figure 4. Relaxation Time Distributions for responses of
human gut commensals to repeated antibiotic exposures. Each
relaxation time constant characterizes the time for a reference
operational taxonomic unit (refOTU) to reach an equilibrium relative
abundance level in the ecosystem after an antibiotic pulse. Probability
density functions were estimated for either the first post-antibiotic
exposure interval (solid blue line, ‘‘1
st relaxation time’’) or the second
post-antibiotic exposure interval (dashed red line, ‘‘2
nd relaxation
time’’). A smoothing kernel algorithm was used to estimate probability
density functions, using relaxation time constants from refOTUs from all
subjects (756 time constants for each post-antibiotic exposure interval).
doi:10.1371/journal.pcbi.1002624.g004
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averaged over refOTUs and time-points. Evaluation of predictive
accuracy is important to assess the degree to which a probabilistic
model generalizes to new data, without over-fitting features
particular to one dataset. To perform this evaluation, we estimated
optimal experimental designs for each subject, using three design
strategies. For the first strategy, a sequential design, we gave the
experimental design algorithm data for all refOTUs observed at a
subset of time-points, and asked the algorithm to estimate additional
time-points to sample in the same subject. For the second strategy, a
cross-subject design, we gave the experimental design algorithm all
observed data from one subject, and asked the algorithm to estimate
time-points to sample for a different subject. In the third strategy, a
dispersed design, we did not use the experimental design algorithm,
and simply chose time-points to sample that were as evenly spaced
on the study interval as possible. The dispersed design uses no
information from observed data, and thus served as a baseline with
which to compare the other two design strategies.
The two experimental design strategies (sequential and cross-
subject)that use prior information improved on the uninformative
dispersed strategy by an average of 13%, as measured by reduction
in prediction accuracy (RMSE). Of the two informative strategies,
neither consistently dominated the other. However, the cross-
subject strategy did substantially outperform the sequential
strategy for subject D. This subject exhibited the highest Signature
Diversity equilibrium level (SD1m) score, meaning that many
refOTUs in this subject changed equilibrium levels subsequent to
one or both antibiotic exposures. Consequently, equilibrium levels
for refOTUs in subject D were harder to predict from prior
equilibrium levels. Thus, the sequential design strategy, which uses
only partial time-series data as input to the design algorithm,
suffered in performance. In contrast, the cross-subject strategy that
uses complete data from another subject, performed particularly
well for subject D, because it leveraged prototype signatures
predicted from subject E or F that were substantially similar to
those in subject D.
Figure 5. Consensus Signature Groups of human gut commensals ordered by relaxation time after first antibiotic pulse. Each panel
(A–M) depicts a Consensus Signature Group (CSG), with signatures conformed to a common time-scale and amplitude to facilitate comparison across
subjects and CSGs. Displayed CSGs are those containing at least one reference operational taxonomic units (refOTUs) shared among all subjects, and
significantly enriched for at least one taxonomic label at the family or genus level (false discovery rate ,0.05, hypergeometric tests). The horizontal
axis indicates time in days and the vertical axis indicates normalized signature amplitude. Red dashed lines depict median inferred signatures, and
shaded red areas indicate 95% credible intervals. Horizontal blue lines depict antibiotic exposure windows. Numbers above plots indicate relaxation
time constants in units of days.(A–H) are CSGs showing decreases in relative abundance during the first antibiotic pulse, and (I–M) are CSGs showing
increases in relative abundance during the first antibiotic pulse.
doi:10.1371/journal.pcbi.1002624.g005
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We presented MC-TIMME, a unified computational frame-
work for inferring dynamic signatures of the microbiota from high-
throughput sequencing time-series datasets, and applied our
framework to discover new features of the in vivo response of
human gut microbes to antibiotic treatments. Our work represents
both biologically and computationally significant advances. From
the biological perspective, our study provides new insights into the
differential and dynamic effects of antibiotic treatments on
commensal bacteria in the human gut. Antibiotics disrupt the
commensal flora, which can contribute to overgrowth and
pathogenic effects of organisms such as Clostridium difficile, the
cause of pseudomembranous colitis [61]. However, antibiotic
effects have primarily been studied in pathogens; the range of
effects on complex commensal populations remains largely
unknown. Our results provide evidence, consistent across multiple
human subjects, that sub-groups of commensals exhibit distinct
temporal responses to treatment with a broad spectrum antibiotic.
These results illustrate the staged dynamics of responses among
sub-populations of commensals, and will enable future experi-
mental studies to characterize the underlying molecular mecha-
nisms behind these differential responses. From the computational
standpoint, our study provides a robust, general-purpose frame-
work for extracting fundamental information on ecosystem
dynamics from massive sequencing datasets. Our framework
may be applied to types of data other than 16S phylotypes, such as
metagenomics or RNA Seq data, as well as model systems in
animal or plant hosts, or studies in soil or marine environments.
MC-TIMME employs probabilistic models of dynamics and
associated measures of their properties, which yield important
functional information that standard techniques for analyzing
microbial communities cannot. Our use of adaptive Bayesian
methods not only increases the strength of statistical inferences,
but also provides signatures of microbial responses that are robust
across multiple experimental subjects. Additionally, MC-TIMME
enables optimal design of new time-series experiments, which will
provide a strong foundation for future longitudinal studies of the
microbiota.
Our results on automated experimental design strategies have
implications for how future longitudinal studies of the microbiota
should be designed. An automated cross-subject design strategy
generally performed comparably to or better than a sequential
design strategy. A cross-subject design strategy uses all data from
one subject to predict a future experimental design for a second
subject. In contrast, a sequential design strategy uses limited
samples from one subject to predict a future experimental design
for the same subject. In the past, when the costs of experimentally
interrogating samples were high, strategies using automated design
were advocated in which samples would be over-collected, frozen,
Figure 6. Optimized experimental design for studying responses of the human gut microbiota to repeated antibiotic exposures.
Each panel (A–C) depicts an optimized design for one subject in the study. (A) Subject D. (B) Subject E. (C) Subject F. The rows in each panel depict
the time-points from the optimal (‘‘opt’’) and original (‘‘org’’) designs. Times are in days from the start of the experiments. Time-points that overlap in
both designs are shown in green boxes. Time-points that are unique to either of the optimal or original designs are depicted with colored numbers
(optimal=purple, original=orange). The two antibiotic exposure intervals are shown as blue rectangles.
doi:10.1371/journal.pcbi.1002624.g006
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next samples to interrogate [24]. Our findings suggest that, in an
era of plummeting sequencing costs, automated experimental
designs based on pilot studies with small cohorts may prove more
effective, particularly for clinical trials in which sample collection
costs and logistics can be the limiting factors. However,
confirmation of this hypothesis will require larger numbers of
subjects and more detailed information about the heterogeneity of
cohorts, with respect to factors such as demographics and
environmental exposures. Additionally, we used a general-
purpose, information theoretic utility function as a basis for
selecting optimal experimental designs. This utility function has
proven useful in many prior studies (see e.g., [46]), and performed
well in our analyses. However, our framework for experimental
design could readily be extended, by using utility functions that
explicitly include financial or other costs involved in performing
experiments.
Analysis of host microbial ecosystems solely by 16S phylotyping
has inherent limitations. Sequencing based methods suffer from
various biases, due to factors such as the DNA extraction method
and sequencing platform utilized [62]. Additionally, from 16S
phylotyping data, it is only possible to infer abundances of taxa
relative to other members of the microbial ecosystem detected with
sequencing, and not the actual biomasses of individual taxa
relative to the input mass of material analyzed. Thus, from our
relaxation time analysis, one cannot infer the time required for
taxa to equilibrate in terms of their absolute biomasses in vivo.
Nonetheless, many studies have shown that relative abundances of
organisms serve as important ecological indicators [2]. Relative
abundances reflect differential abilities of organisms to compete for
and effectively use limited resources, and thus provide insights into
the roles of sub-communities within larger host ecosystems.
However, the most profound limitation to 16S phylotyping data
is that it is only useful for identifying which bacteria are present,
not what they are doing. Ultimately, targeted or high-throughput
functional studies [63] are essential for following up hypotheses
generated based on 16S phylotyping.
MC-TIMME can be extended with alternate models of
dynamics for analyzing other time-series datasets. The key
components of the model, including the infinite mixture model
for prototype signatures and the noise model for counts data,
employ general-purpose inference techniques that would not need
to be modified to accommodate different models of dynamics.
However, the Reversible Jump MCMC techniques we used for
inference of intra-signature dimensionality changes require model-
specific moves; in future work, more general techniques such as
sparse priors [64,65]could be employed for inference of this
portion of the model. For the experimental system we modeled,
with defined antibiotic administrations, we assumed that pertur-
bations to the microbiota start at known time-points. This model
of dynamics could be extended for analyzing observational studies,
in which naturally occurring perturbations may occur, by adding
latent variables that automatically determine switch-points in
dynamics. Another direction for extension would be building more
elaborate relaxation time models. We used a relaxation time
model based on ordinary differential equations, which assumes
instantaneous transitions to different dynamic regimes and
monotonic exponential decay to equilibrium levels. A more
detailed model could allow smooth transitions between regimes,
and richer kinetics of decay to equilibrium, to capture more subtle
or chronic responses to perturbations. Additionally, more complex
temporal correlations could be captured using a stochastic
differential equation model such as the Ornstein-Uhlenbeck
process [66]. Finally, longitudinal covariates, such as subject diet,
could be added to the model of dynamics to capture exogenous
factors that may affect the microbiota. Such extensions to MC-
TIMME will enable increasingly sophisticated longitudinal studies,
to expand our knowledge of the role of the microbiota in human
health or disease.
Supporting Information
Figure S1 Model of dynamics for prototype signatures.
An example of a prototype signature (solid blue line) is depicted.
The model of dynamics for each prototype signature is a function
continuous in both time and values, which is used to
parameterize the mean of the negative binomial distribution
(NBD). The function is defined piece-wise on 5 intervals: (A) pre-
antibiotic exposure, (B) first antibiotic pulse, (C) first post-
antibiotic exposure, (D) second antibiotic pulse, and (E) second
post-antibiotic exposure. The function is constant on intervals A,
B and D. On intervals C and E, the function follows an
exponential relaxation process with initial value X, equilibrium
value m, and relaxation time constant l; an equation for the
corresponding relaxation process is shown above intervals C and
E. Equilibrium levels for each interval are depicted at the right of
the figure.
(TIF)
Figure S2 Representative individual signatures of
human gut commensals perturbed by antibiotic
pulses. Panels (A–F) depict normalized individual signatures
for reference operational taxonomic units (refOTUs) from a
single human subject. The vertical axis represents sequencing
counts per 10,000 total reads normalized across experiments.
The horizontal axis represents time in days since the start of
the experiment. Vertical blue lines depict the two windows of
antibiotic exposure (56 to 60 and 238 to 242 days). Dashed red
lines depict median inferred individual signatures, and shaded
red areas depict 95% credible intervals. Each refOTU is
labeled with its number from the original dataset and its
taxonomic assignment at the family and genus levels. The
symbol lc denotes the inferred median relaxation time constant
on the first post-antibiotic interval, and le denotes the
corresponding relaxation time constant on the second post-
antibiotic interval. The symbols ma, mc, and me denote the
equilibrium levels on pre- and first and second post-antibiotic
intervals. The five probabilities shown indicate the probability
that: 1) the relaxation times on both post-antibiotic intervals
are equal, and 2–5) the three equilibrium levels on the pre-
and first and second post-antibiotic intervals have a particular
pattern.
(TIF)
Figure S3 Predictive performance of the experimental
design algorithm using different design strategies.
Predictive performance was evaluated on held-out time-points,
with accuracy assessed using root mean square error (RMSE). (A)
The sequential design strategy used data for all reference
operational taxonomic units (refOTUs) observed at a subset of
time-points in a subject, to estimate additional time-points to
sample in the same subject. (B) The cross-subject design strategy
used all observed data from refOTUs in one subject, and
estimated time-points to sample in a different subject. A dispersed
design strategy was used as a baseline for comparison. The
dispersed design did not use the experimental design algorithm,
and chose time-points to sample that were as evenly spaced on
the study interval as possible.
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